The nomenclature LOC643008 Activators suggests a theoretical group of chemical substances designed to specifically bind to and increase the activity of a protein that would be encoded by a genetic locus named LOC643008. As of the latest scientific data available to me, LOC643008 does not correspond to any documented gene or protein, therefore any discussion regarding substances described as LOC643008 Activators must be considered a speculative exercise. Assuming LOC643008 were a valid and characterized gene, activators targeting this gene product would be molecules that engage in direct or indirect interactions to upregulate its biological activity. The interactions could be diverse, potentially including direct binding to the protein's active site to enhance its function, binding to an allosteric site to induce a favorable conformational change, or modulation of the protein's interactions with other cellular machinery to amplify its activity. The discovery and validation of such activators would likely involve a variety of in vitro assays to measure the increase in activity of the protein in the presence of these molecules, alongside computational modeling to predict potential binding sites and affinities.
To gain a comprehensive understanding of LOC643008 Activators, a series of detailed studies would be necessary. These would encompass both biophysical and biochemical techniques. For instance, researchers might utilize affinity-based assays, such as fluorescence resonance energy transfer (FRET) or enzyme-linked immunosorbent assays (ELISA), to quantify the interaction between the LOC643008 protein and potential activators. Structural biology methods like X-ray crystallography or cryo-electron microscopy would be invaluable for elucidating the molecular details of where and how these activators bind to the protein. Such structural insights could reveal not only the precise binding pocket but also any conformational rearrangements of the protein that occur upon activation. Complementary to these experimental approaches, in silico modeling, such as molecular docking and dynamics simulations, would provide predictive insights into the interaction patterns and might help in identifying key amino acid residues involved in the activation process. This integrative strategy, combining empirical data with computational predictions, would be essential to thoroughly characterize the mechanism of action of LOC643008 Activators at the molecular level.
関連項目
Items 1 to 10 of 12 total
画面:
| 製品名 | CAS # | カタログ # | 数量 | 価格 | 引用文献 | レーティング |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
この化合物はDNAメチル化酵素阻害剤であり、サイレンシングされた遺伝子を再活性化し、アンチセンスRNAの発現に影響を与える可能性がある。 | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMAはプロテインキナーゼCを活性化し、アンチセンスRNAを含む遺伝子発現パターンを変化させる。 | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
ヒストン脱アセチル化酵素阻害剤として、クロマチン構造を変化させ、アンチセンスRNAを含む可能性のある遺伝子発現を誘導することができる。 | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
レチノイン酸は核内受容体に作用し、遺伝子や関連するアンチセンスRNAの発現を変化させることができる。 | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
主に転写を阻害することが知られているが、ストレス応答として特定の遺伝子や潜在的にアンチセンスRNAのアップレギュレーションを引き起こすこともある。 | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
このヒストン脱アセチル化酵素阻害剤は、多数の遺伝子の発現レベルを変化させ、おそらくアンチセンスRNA分子に影響を与える。 | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
メトトレキサートは、葉酸代謝およびDNA合成に対する作用の結果として、遺伝子発現に変化を引き起こす可能性がある。 | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
リチウムはWnt経路などいくつかのシグナル伝達経路に影響を与え、アンチセンスRNAを含む遺伝子発現の変化を引き起こす可能性がある。 | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
エトポシドはDNA複製を阻害し、遺伝子発現プロファイルを変化させるが、それはアンチセンスRNAにまで及ぶ可能性がある。 | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
GCリッチなDNA配列に結合することで、特定の遺伝子の転写を特異的に変化させ、アンチセンスRNAの発現に影響を与える可能性がある。 | ||||||